Literature DB >> 19931400

BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents.

Jennifer Y F Lau1, David Goldman, Beata Buzas, Colin Hodgkinson, Ellen Leibenluft, Eric Nelson, Lindsey Sankin, Daniel S Pine, Monique Ernst.   

Abstract

A polymorphism of the human Brain Derived Neurotrophic Factor (BDNF) gene that produces a valine-to-methionine substitution at codon 66 (Val66Met) is linked to adult anxiety and mood disorders, possibly through effects on brain circuitry function. Associations between BDNF gene variants and brain activity have not been explored in anxious and depressed adolescents. The current study investigated the association between BDNF genotype and amygdala-hippocampal responses to emotional stimuli in adolescents with anxiety disorders and/or major depressive disorder (MDD) and in healthy adolescents. Twenty-seven unmedicated patients with acutely-impairing current anxiety disorders and/or MDD and 31 healthy adolescents, matched on age, gender and IQ, rated their fear of fearful, angry, neutral and happy facial expressions during collection of fMRI data on the amygdala and hippocampus. Left and right amygdala and hippocampal responses were analyzed using repeated-measures analyses of variance models, with diagnosis (patients, healthy) and genotype (Met-carriers, Val/Val homozygotes) as between-group factors and facial expression (fearful, angry, neutral, happy) as a within-subject factor. Significant effects of diagnosis and diagnosis-by-genotype interactions (F's>4, p's<0.05) characterized activations in amygdala and anterior hippocampal regions. Greater activations in patients than healthy adolescents were found. Critically, these hyperactivations were modulated by BDNF genotype: Met-carriers showed greater neural responses of emotional faces than Val/Val homozygotes in patients only. These data are first to demonstrate the contribution of BDNF gene variants to the neural correlates of adolescent anxiety and depression. Early "gene-brain" linkages may lay the foundation for longer-term patterns of neural dysfunction in affective disorders. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931400      PMCID: PMC2888869          DOI: 10.1016/j.neuroimage.2009.11.026

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  62 in total

1.  K-SADS-PL.

Authors:  J Kaufman; B Birmaher; D A Brent; N D Ryan; U Rao
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-10       Impact factor: 8.829

Review 2.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 3.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

Review 4.  Depression: perspectives from affective neuroscience.

Authors:  Richard J Davidson; Diego Pizzagalli; Jack B Nitschke; Katherine Putnam
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

5.  Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems.

Authors:  Peter R Schofield; Leanne M Williams; Robert H Paul; Justine M Gatt; Kerri Brown; Agnes Luty; Nicholas Cooper; Stuart Grieve; Carol Dobson-Stone; Charlotte Morris; Stacey A Kuan; Evian Gordon
Journal:  Biol Psychol       Date:  2008-09-16       Impact factor: 3.251

6.  Addictions biology: haplotype-based analysis for 130 candidate genes on a single array.

Authors:  Colin A Hodgkinson; Qiaoping Yuan; Ke Xu; Pei-Hong Shen; Elizabeth Heinz; Elizabeth A Lobos; Elizabeth B Binder; Joe Cubells; Cindy L Ehlers; Joel Gelernter; John Mann; Brien Riley; Alec Roy; Boris Tabakoff; Richard D Todd; Zhifeng Zhou; David Goldman
Journal:  Alcohol Alcohol       Date:  2008-05-12       Impact factor: 2.826

7.  Amygdala response to fearful faces in anxious and depressed children.

Authors:  K M Thomas; W C Drevets; R E Dahl; N D Ryan; B Birmaher; C H Eccard; D Axelson; P J Whalen; B J Casey
Journal:  Arch Gen Psychiatry       Date:  2001-11

8.  Using genetic analyses to clarify the distinction between depressive and anxious symptoms in children.

Authors:  T C Eley; J Stevenson
Journal:  J Abnorm Child Psychol       Date:  1999-04

9.  The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: An attempt at replication.

Authors:  Marieke Wichers; Gunter Kenis; Nele Jacobs; Ron Mengelers; Catherine Derom; Robert Vlietinck; Jim van Os
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-01-05       Impact factor: 3.568

10.  Gene-environment interaction analysis of serotonin system markers with adolescent depression.

Authors:  T C Eley; K Sugden; A Corsico; A M Gregory; P Sham; P McGuffin; R Plomin; I W Craig
Journal:  Mol Psychiatry       Date:  2004-10       Impact factor: 15.992

View more
  51 in total

Review 1.  Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease.

Authors:  Cunlu Xu; Zhenhua Wang; Ming Fan; Bing Liu; Ming Song; Xiantong Zhen; Tianzi Jiang
Journal:  Neuroreport       Date:  2010-08-23       Impact factor: 1.837

Review 3.  Imaging-genetics applications in child psychiatry.

Authors:  Daniel S Pine; Monique Ernst; Ellen Leibenluft
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-04-09       Impact factor: 8.829

4.  Brain-derived neurotrophic factor Val⁶⁶Met polymorphism affects resting regional cerebral blood flow and functional connectivity differentially in women versus men.

Authors:  Shau-Ming Wei; Daniel P Eisenberg; Philip D Kohn; Jonathan S Kippenhan; Bhaskar S Kolachana; Daniel R Weinberger; Karen F Berman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

5.  Interactive effect of 5-HTTLPR and BDNF polymorphisms on amygdala intrinsic functional connectivity and anxiety.

Authors:  Joshua Loewenstern; Xiaozhen You; Junaid Merchant; Evan M Gordon; Melanie Stollstorff; Joseph Devaney; Chandan J Vaidya
Journal:  Psychiatry Res Neuroimaging       Date:  2019-01-29       Impact factor: 2.376

Review 6.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

7.  Brain-derived neurotrophic factor association with amygdala response in major depressive disorder.

Authors:  Valentina Lorenzetti; Sergi G Costafreda; Rachael M Rimmer; Mark M Rasenick; Lauren B Marangell; Cynthia H Y Fu
Journal:  J Affect Disord       Date:  2020-01-27       Impact factor: 4.839

Review 8.  Future directions in vulnerability to depression among youth: integrating risk factors and processes across multiple levels of analysis.

Authors:  Benjamin L Hankin
Journal:  J Clin Child Adolesc Psychol       Date:  2012-08-17

9.  Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.

Authors:  Mu-En Liu; Chu-Chung Huang; Mu-Hong Chen; Albert C Yang; Pei-Chi Tu; Heng-Liang Yeh; Chen-Jee Hong; Jin-Fan Chen; Jen-Ping Hwang; Ching-Po Lin; Shih-Jen Tsai
Journal:  Neuromolecular Med       Date:  2013-12-24       Impact factor: 3.843

10.  Gray matter volume in adolescent anxiety: an impact of the brain-derived neurotrophic factor Val(66)Met polymorphism?

Authors:  Sven C Mueller; Aveline Aouidad; Elena Gorodetsky; David Goldman; Daniel S Pine; Monique Ernst
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.